Parkside Financial Bank & Trust’s Medicines Co MDCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-87
Closed -$4K 1679
2019
Q3
$4K Sell
87
-6
-6% -$239 ﹤0.01% 1028
2019
Q2
$3K Buy
93
+17
+22% +$555 ﹤0.01% 1125
2019
Q1
$2K Buy
76
+50
+192% +$1.18K ﹤0.01% 1250
2018
Q4
$0 Sell
26
-19
-42% -$442 ﹤0.01% 1648
2018
Q3
$1K Hold
45
﹤0.01% 1481
2018
Q2
$2K Buy
45
+3
+7% +$97 ﹤0.01% 1139
2018
Q1
$1K Buy
42
+35
+500% +$1.09K ﹤0.01% 1394
2017
Q4
$0 Sell
7
-33
-83% -$1.02K ﹤0.01% 1558
2017
Q3
$1K Hold
40
﹤0.01% 1311
2017
Q2
$2K Hold
40
﹤0.01% 1034
2017
Q1
$2K Hold
40
﹤0.01% 1020
2016
Q4
$1K Buy
+40
New +$1.42K ﹤0.01% 1297

Other funds holding MDCO

Parkside Financial Bank & Trust's MDCO Position: Q4 2019 in Review

Parkside Financial Bank & Trust sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 87 shares — an estimated $4K sold.

Parkside Financial Bank & Trust first reported a position in MDCO in Q4 2016 and held it in 12 quarters. The position peaked at $4K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • Parkside Financial Bank & Trust reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 87 Medicines Co shares in Q4 2019, an estimated $4K.
  • Parkside Financial Bank & Trust first reported a position in Medicines Co in Q4 2016 and held it in 12 quarters.
  • Parkside Financial Bank & Trust's Medicines Co position peaked at $4K in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2019, filed 30 Jan 2020.